Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/1b/46/9c/1b469cf6-a85d-2977-1ac5-51f92ef65669/mza_5261734729492018704.jpg/600x600bb.jpg
TechSurge: Deep Tech Podcast
Celesta Capital | Deep Tech Venture Capital Firm
26 episodes
1 day ago
The TechSurge: Deep Tech VC Podcast explores the frontiers of emerging tech, geopolitics, and business, with conversations tailored for entrepreneurs, technologists, and investment professionals. Presented by Celesta Capital, and hosted by Founding Partners Nic Brathwaite, Michael Marks, and Sriram Viswanathan. Send feedback and show ideas to techsurge@celesta.vc. Each discussion delves into the intersection of technology advancement, market dynamics, and the founder journey, offering insights into the vast opportunities and complex challenges ahead. Episode topics include AI, data center transformation, blockchain, cyber security, healthcare innovation, VC investment trends, tips for first-time founders, and more. Tune in to hear directly from Silicon Valley leaders, daring new founders, and visionary thinkers. Past guests include investor Vinod Khosla, former PepsiCo CEO Indra Nooyi, the Global Head of McKinsey, and executive leaders from Microsoft, OpenAI, and other leading tech companies. New episodes release every two weeks. Visit techsurgepodcast.com for more details and to sign up for our newsletter and other content!
Show more...
Technology
Business,
Investing
RSS
All content for TechSurge: Deep Tech Podcast is the property of Celesta Capital | Deep Tech Venture Capital Firm and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The TechSurge: Deep Tech VC Podcast explores the frontiers of emerging tech, geopolitics, and business, with conversations tailored for entrepreneurs, technologists, and investment professionals. Presented by Celesta Capital, and hosted by Founding Partners Nic Brathwaite, Michael Marks, and Sriram Viswanathan. Send feedback and show ideas to techsurge@celesta.vc. Each discussion delves into the intersection of technology advancement, market dynamics, and the founder journey, offering insights into the vast opportunities and complex challenges ahead. Episode topics include AI, data center transformation, blockchain, cyber security, healthcare innovation, VC investment trends, tips for first-time founders, and more. Tune in to hear directly from Silicon Valley leaders, daring new founders, and visionary thinkers. Past guests include investor Vinod Khosla, former PepsiCo CEO Indra Nooyi, the Global Head of McKinsey, and executive leaders from Microsoft, OpenAI, and other leading tech companies. New episodes release every two weeks. Visit techsurgepodcast.com for more details and to sign up for our newsletter and other content!
Show more...
Technology
Business,
Investing
https://img.transistor.fm/Rte_xr-4g6BwfV1tV3S8APlZqp_02UOZ6iM0UyKN-Zg/rs:fill:3000:3000:1/q:60/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mZmE3/NDdjMmRjZThmYmNh/YzczY2YwZmE5Zjcz/ODZkMC53ZWJw.jpg
Why AI Isn't Ready to Make Medicines
TechSurge: Deep Tech Podcast
41 minutes
8 months ago
Why AI Isn't Ready to Make Medicines

Many in venture capital and biopharma are anointing artificial intelligence the savior of drug discovery—but what can AI actually do?

In this eye-opening episode, Michael Marks sits down with Mike Nohaile, CEO of Prellis Biologics, to explore the hype versus reality in AI-enabled drug discovery. Mike details why, despite significant breakthroughs like AlphaFold and recent Nobel Prize win for computational protein design, fully AI-generated medicines still present challenges. He also discusses why we urgently need more effective medicines and details Prellis’ unique system which combines laser printed human organoids and an externalized human immune system with AI, enabling the discovery of fully human antibodies. 

If you enjoy this episode, please subscribe and leave us a review on your favorite podcast platform. Sign up for our newsletter at techsurgepodcast.com for exclusive insights and updates on upcoming TechSurge Live Summits.

Links:

Explore Prellis Biologics

https://prellisbio.com/

Understand AlphaFold, DeepMind’s AI model for predicting protein structures

https://deepmind.google/alphafold


Read about the 2024 Nobel Prize in Chemistry 

https://www.nobelprize.org/prizes/chemistry/2024/press-release/ 

TechSurge: Deep Tech Podcast
The TechSurge: Deep Tech VC Podcast explores the frontiers of emerging tech, geopolitics, and business, with conversations tailored for entrepreneurs, technologists, and investment professionals. Presented by Celesta Capital, and hosted by Founding Partners Nic Brathwaite, Michael Marks, and Sriram Viswanathan. Send feedback and show ideas to techsurge@celesta.vc. Each discussion delves into the intersection of technology advancement, market dynamics, and the founder journey, offering insights into the vast opportunities and complex challenges ahead. Episode topics include AI, data center transformation, blockchain, cyber security, healthcare innovation, VC investment trends, tips for first-time founders, and more. Tune in to hear directly from Silicon Valley leaders, daring new founders, and visionary thinkers. Past guests include investor Vinod Khosla, former PepsiCo CEO Indra Nooyi, the Global Head of McKinsey, and executive leaders from Microsoft, OpenAI, and other leading tech companies. New episodes release every two weeks. Visit techsurgepodcast.com for more details and to sign up for our newsletter and other content!